AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CPAC

Cementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares) (CPAC) fair value

Basic Materials · Building Materials · NYSE · United States
$12.73-0.31%
Market cap $1.1BNext earnings 2026-10-27Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 44% above our fair value
Price
$12.73
Model fair valueConfidence: good
$8.86
Model range
$6.28 to $11.48
Fair value $8.86
Price $12.73
5 models fit Cementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares) and they disagree: 2 of 5 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver71
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionCementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares) (CPAC)
Fair value (5 models)
$8.86
ACCE price target
$11.50
Rating
Overvalued
Horizon
12 months
Fair value published on 19 Oct 2026, 18:04 CEST; previously $7.55 since 7 Oct 2026, 00:00 CEST.
ACCE price target published on 13 Oct 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 18:04 CEST.
Price used: $12.73 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
43.8% above
-30.4% to fair value
ACCE score
82
out of 100
Analysts
0% buy
3 covering
P/E
18.0x
forward 14.2x
1-year return
+75.6%
Dividend yield
4.76%

Cementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares) in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Cementos Pacasmayo is a Peruvian producer of cement, ready-mix concrete, lime and precast products, selling mainly under the Portland and Cemento Sol brands into the Peruvian construction market. Its main structural edge is a vertically integrated cost base: it runs its own limestone quarries, clinker kilns and distribution, which helps explain a 40.0% gross margin and a 24.4% operating margin in an industry where pricing is largely commodity-driven. Revenue growth of 15.4% gives the stock a near-term driver, with the company's exposure to Peruvian infrastructure and private construction spend the main variable to watch. At 14.2 times forward earnings against a trailing 17.8 times, the multiple implies the market expects earnings to rise, and a 16.0% return on equity indicates that growth is being earned rather than bought. The stock is a small-cap with an emerging-market domicile and no index membership, so liquidity, currency and Peruvian political risk need the closest scrutiny before any position is considered.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 1 flagAI-assisted·How I use AI
  • moderate
    Leverage elevated
    Debt/Equity of 1.20 is high for a cyclical cement producer, so a downturn in Peruvian construction would hit earnings and debt service together.

AI research notes

AI-assisted·How I use AIWritten Oct 13, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 15.4% year over year in the latest filing, well above its 10.3% average annual pace over five years.
  • The stock trades at 14.2x forward earnings, and its latest quarterly earnings beat expectations by 47.5%.
  • A 5.0% dividend yield pays shareholders while they wait for the business to keep growing.
Why it could disappoint
  • Return on invested capital is just 4.8%, a thin cushion for a business carrying debt equal to 1.20 times its equity.
  • The share price implies cash flow shrinking 6.4% a year for five years, a pessimistic view that the company must disprove.
  • None of the three analysts covering the stock rates it Buy or Strong Buy, and their mean target is only 4.3% above the price.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Oct 27, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CPAC's valuation models land
Price
$12.73
Model fair value
$8.86
Model range
$6.28 to $11.48
Fair value $8.86
Price $12.73
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish0% buy · 3 covering analysts
● Strong buy 0● Buy 0● Hold 3● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+0.4%
1 month
+3.4%
3 months
+6.5%
6 months
+19.0%
YTD
+22.2%
1 year
+75.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 18:04 CESTRatingOvervaluedfirst publication$12.68
19 Oct 2026, 18:04 CESTFair value$8.86$7.55$12.68
13 Oct 2026, 00:00 CESTACCE price target$11.50first publication$12.27
7 Oct 2026, 00:00 CESTFair value$7.55$7.64$12.21
4 Oct 2026, 00:00 CESTFair value$7.64$7.29$12.32
30 Sept 2026, 00:00 CESTFair value$7.29$7.44$12.16
23 Sept 2026, 00:00 CESTFair value$7.44$7.51$12.39
20 Sept 2026, 00:00 CESTFair value$7.51$11.48$12.39
18 Sept 2026, 00:00 CESTFair value$11.48$10.88$12.61
16 Sept 2026, 00:00 CESTFair value$10.88$11.05$12.52

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CPAC page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth88Value83Quality67Momentum90Total82
Valuation
Trailing P/E
18.0x
Forward P/E
14.2x
PEG
1.13
P/B
2.71x
EV / Revenue
2.2x
Book value/sh
PEN 4.45
Enterprise value
$1.4B
Profitability
ROE
16.0%
FCF yield
6.52%
ROIC
4.8%
Health and risk
Debt / equity
1.20
Dividend yield
4.76%
Beta
0.12

Price

+71.3% · 1Y

Ask anything about CPAC

Answered from Cementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares) fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 60% of peers
low 13.5x18.0xhigh 35.6x
ROEbetter than 83% of peers
low -16%16%high 17%
Div yieldbetter than 83% of peers
low 0.0%4.8%high 9.8%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CPAC Cementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares)$12.73$944% above18.0x16.0%6782
LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS$9.44--31.5x3.8%4752
LOMA.BA Loma Negra Compania Industrial Argentina SAARS 3065.00--35.6x3.8%4753
2009.HK BBMG CorporationHK$0.59----3.0%1321
BREE.L Breedon Group plc£3.25£410% below13.8x6.9%6060
TGLS Tecnoglass Inc. Ordinary Shares$38.72$5327% below13.5x17.0%7154
RMIX Suncrete Inc. Class A Common Stock$9.35--24.6x-15.7%3938

Sector report card

Where CPAC ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Jul 20, 2026
    Cementos Pacasmayo S.A.A. Announces Consolidated Results for Second Quarter 2026
  • Business Wire•Apr 28, 2026
    Cementos Pacasmayo S.A.A. Has Filed Its Annual Report for the Fiscal Year Ended December 31, 2025
  • Business Wire•Apr 25, 2026
    Cementos Pacasmayo S.A.A. Announces Consolidated Results for First Quarter 2026
1 more press releases · full archive on Investor+.INVESTOR
36 filings of 40
October 2026
Oct 16
6-KForeign current reportPeriod 2026-10-16
View on SEC →
Oct 15
6-KForeign current reportPeriod 2026-10-15
View on SEC →
Oct 15
6-KForeign current reportPeriod 2026-10-15
View on SEC →
33 more filings + AI summaries on Investor+.INVESTOR